L Lisata Therapeutics
L
Затворен
3.43 0.59
Преглед
Промяна на цената на акция
24 ч
Минимум
3.38
Максимум
3.45
Приходи | -1.5M -4.5M |
|---|---|
Марж на печалбата | -2,954 |
Служители | 21 |
Следващи печалби | 6.08.2026 г. |
|---|
Пазарна капитализация | 3.5M 27M |
|---|---|
Предишно отваряне | 2.84 |
Предишно затваряне | 3.43 |
Lisata Therapeutics Графика
Миналото представяне не гарантира бъдещи резултати.
Относно Lisata Therapeutics
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
